CHARACTERIZATION OF 4 MUTATIONS IN THE NEUROFIBROMATOSIS TYPE-1 GENE BY DENATURING GRADIENT GEL-ELECTROPHORESIS (DGGE)

被引:37
作者
VALERO, MC [1 ]
VELASCO, E [1 ]
MORENO, F [1 ]
HERNANDEZCHICO, C [1 ]
机构
[1] HOSP RAMON Y CAJAL, UNIDAD GENET MOLEC, E-28034 MADRID, SPAIN
关键词
D O I
10.1093/hmg/3.4.639
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neurofibromatosis type 1 (NF1) is one of the most common inherited disorders. The gene responsible for the disease has a very high mutation rate, approximately fifty per cent of NF1 patients appear to have a de novo mutation. The search for mutations is hampered by the large size of the NF1 gene and up to date, relatively few mutations have been characterized. In the present work, we report the results of screening seventy unrelated NF1 patients for mutations in NF1 exons 29 and 31 by using an experimental approach that combines the polymerase chain reaction (PCR) with denaturing gradient gel electrophoresis (DGGE). Four mutations were identified and characterized. Three of them consist of C-T transitions resulting in nonsense mutations, two in exon 29, C5242T and C5260T, and one in exon 31, C5839T. The fourth mutation consists of a two-base pair deletion in exon 31, 5843delAA, also resulting in a premature stop codon. The finding in our patients of mutation C5839T, previously reported in three independent studies, supports that this position is a hotspot within the NF1 gene.
引用
收藏
页码:639 / 641
页数:3
相关论文
共 26 条
[1]  
AINSWORTH PJ, 1993, HUM GENET, V91, P151
[2]   A NEW DISEASE-CAUSING MUTATION IN THE GAP-RELATED DOMAIN OF THE NF1 GENE [J].
ANGLANI, F ;
MURGIA, A ;
BEDIN, S ;
BRESIN, E ;
BERNARDI, F ;
CLEMENTI, M ;
TENCONI, R .
HUMAN MOLECULAR GENETICS, 1993, 2 (07) :1057-1059
[3]   Growth rate characteristics of acoustic neuromas associated with neurofibromatosis type 2 [J].
Abaza, MM ;
Makariou, E ;
Armstrong, M ;
Lalwani, AK .
LARYNGOSCOPE, 1996, 106 (06) :694-699
[4]   A MAJOR SEGMENT OF THE NEUROFIBROMATOSIS TYPE-1 GENE - CDNA SEQUENCE, GENOMIC STRUCTURE, AND POINT MUTATIONS [J].
CAWTHON, RM ;
WEISS, R ;
XU, GF ;
VISKOCHIL, D ;
CULVER, M ;
STEVENS, J ;
ROBERTSON, M ;
DUNN, D ;
GESTELAND, R ;
OCONNELL, P ;
WHITE, R .
CELL, 1990, 62 (01) :193-201
[5]   CHARACTERIZATION OF A SINGLE BASE-PAIR DELETION IN NEUROFIBROMATOSIS TYPE-1 [J].
COLMAN, SD ;
COLLINS, FS ;
WALLACE, MR .
HUMAN MOLECULAR GENETICS, 1993, 2 (10) :1709-1711
[6]   THE CPG DINUCLEOTIDE AND HUMAN GENETIC-DISEASE [J].
COOPER, DN ;
YOUSSOUFIAN, H .
HUMAN GENETICS, 1988, 78 (02) :151-155
[7]  
ESTIVILL X, 1991, HUM GENET, V88, P185
[8]   LARGE DENOVO DNA DELETION IN A PATIENT WITH SPORADIC NEUROFIBROMATOSIS-1, MENTAL-RETARDATION, AND DYSMORPHISM [J].
KAYES, LM ;
RICCARDI, VM ;
BURKE, W ;
BENNETT, RL ;
STEPHENS, K .
JOURNAL OF MEDICAL GENETICS, 1992, 29 (10) :686-690
[9]   CPG ISLANDS AS GENE MARKERS IN THE HUMAN GENOME [J].
LARSEN, F ;
GUNDERSEN, G ;
LOPEZ, R ;
PRYDZ, H .
GENOMICS, 1992, 13 (04) :1095-1107
[10]   NOVEL ALLELES, HEMIZYGOSITY AND DELETIONS AT AN ALU-REPEAT WITHIN THE NEUROFIBROMATOSIS TYPE-1 (NF1) GENE [J].
LAZARO, C ;
GAONA, A ;
RAVELLA, A ;
VOLPINI, V ;
CASALS, T ;
FUENTES, JJ ;
ESTIVILL, X .
HUMAN MOLECULAR GENETICS, 1993, 2 (06) :725-730